Beta Bionics, Inc.: Truist Securities raises target price to $28 from $23
BBNX•Truist Securities raised its target price for Beta Bionics to $28 from $23.
Related News
Commerzbank could buy UniCredit's HVB as part of bank tie-up, CEO says
CBK•
Pasqal ramps up growth plans after Nasdaq listing strengthens balance sheet
PSQL•
Lovesac to present at Telsey-Santander Global Consumer & Retail Conference
LOVE•
Asarian Energy says Namibia renews Namibplaas uranium prospecting licence to September 2028
URA•
Acadia announces Phase 2 results for remlifanserin in Alzheimer’s disease psychosis
ACAD•